This filing is a routine reaffirmation of existing guidance with no new information. Traders should monitor the next quarterly earnings report for any changes to the outlook or operational trends.
How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+20- T+0 · Sep 10 $416.54entry
- T+1 · 2mo ago +0.52%α −0.33% · $418.72
- T+5 · 2mo ago −0.55%α −0.05% · $414.26
- T+20 · 6w ago −3.75%α −5.87% · $400.94
- T+47 · todayOpen
- T+60 · in 17d Pending
Price Chart
How similar events traded
Executive Summary
Elevance Health filed an 8-K to reaffirm its full-year 2026 guidance during upcoming investor meetings. The company expects adjusted shareholders' earnings of at least $27.00 per diluted share and a benefit expense ratio of 90.2% ± 50 bps. This is a routine reaffirmation of existing guidance with no new financial data or changes to the outlook, making it a non-event for traders.
Key Facts
- Reaffirmed FY2026 adjusted shareholders' earnings guidance of at least $27.00 per diluted share.
- Reaffirmed FY2026 GAAP shareholders' earnings guidance of at least $20.10 per diluted share, including ~$6.90 of net unfavorable items.
- Reaffirmed FY2026 benefit expense ratio guidance of 90.2% plus or minus 50 basis points.
- No new financial data or changes to prior guidance were provided.
Financial Impact
No new financial impact; existing guidance reaffirmed with no changes.
Risk Factors
- Healthcare cost and utilization trends could pressure the benefit expense ratio.
- Medicare and Medicaid regulatory changes could impact future earnings.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001156039-26-000063 |
| Document: 0001156039-26-000063-index-headers.html | 0001156039-26-000063 |
| Document: 0001156039-26-000063-index.html | 0001156039-26-000063 |
| Document: 0001156039-26-000063.txt | 0001156039-26-000063 |
Track record
19 reports on ELV
1 of 3 bullish or bearish reports moved the stock their way by T+5. Best: +3.93% at T+5 after the Aug 27, 2026 report. 2 of 3 went positive at some point.
Filters
- Nov 10, 20266d ago 8-K Neutral 2/10 Entry $429.48 Now $446.28 +3.91% settles Nov 18
- Nov 5, 202611d ago 144 Neutral 2/10 Entry $425.62 to $429.69 Now $446.28 +4.85% ▲ +0.96% −1.64% vs SPY
- Oct 28, 202619d ago S-3ASR Neutral 3/10 Entry $422.02 to $432.00 Now $446.28 +5.75% ▲ +2.36% +7.09% vs SPY
- Oct 22, 202625d ago 144 Neutral 2/10 Entry $439.95 to $420.07 Now $446.28 +1.44% ▼ −4.52% −3.96% vs SPY
- Oct 21, 202626d ago 8-K Bullish 7/10 Entry $434.13 to $421.49 Now $446.28 +2.80% ▼ −2.91% −2.47% vs SPY
- Oct 20, 202627d ago Institutional Cluster Neutral 3/10 Entry $434.13 to $421.49 Now $446.28 +2.80% ▼ −2.91% −2.47% vs SPY
- Sep 10, 20269w ago 8-K Neutral 3/10 Viewing Entry $416.54 to $414.26 Now $446.28 +7.14% ▼ −0.55% −0.05% vs SPY
- Aug 27, 202611w ago Institutional Cluster Bullish 6/10 Entry $399.11 to $414.78 Now $446.28 +11.82% ▲ +3.93% +3.66% vs SPY
- Aug 20, 202612w ago Court Ruling Neutral 2/10 Entry $400.54 to $394.43 Now $446.28 +11.42% ▼ −1.53% −2.00% vs SPY
- Aug 17, 202613w ago Court Ruling Neutral 1/10 Entry $396.54 to $397.14 Now $446.28 +12.54% ▲ +0.15% +0.35% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers